Ori Berger

Dr. Ori Berger

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
OBOri Berger
Ori Berger
THTzipi Hornik-Lurie
Tzipi Hornik-Lurie
RTRan Talisman
Ran Talisman
Background: Adolescent gynecomastia, a benign proliferation of male breast tissue, can lead to psychological issues during adolescence. The prevalence varies widely (4%−69%). The incidence peaks are during neonatal, pubertal, and senescent periods. Its affect on emotional well-being necessitates understanding and occasional intervention. This study aimed to determine the incidence of gynecomastia among male adolescents aged 12–15 years.Methods: A retrospective cross-sectional study utilized the Clalit Health Care Services database (2008–2021) with a population of approximately 4.5 million. Participants aged 12–15 years were included if diagnosed with gynecomastia (International classification of diseases-9 code 611.1) and having a body mass index (BMI) measurement and no obesity diagnosis (ICD9 code 278.0). Data analysis included incidence rates and associations with ethnicity, age, BMI, and socioeconomic status.Results: 531,686 participants included with an incidence of 1.08%. Of all participants, 478,140 had a BMI ≤ 25 with an incidence of 0.7%, and 0.25%–0.35% yearly, and 70% of gynecomastia patients were aged 13–14 years. The prevalence of gynecomastia differed between Jews (1.28%) and Arabs (0.67%), but the disparity diminished when socioeconomic status was considered.Conclusions: This unprecedented Population study establishes a definitive rate of true pubertal gynecomastia, revealing a lower yearly incidence as compared to previous reports. The higher observed prevalence among Jewish adolescents, may be caused due to complex interactions between different influencing factors. Understanding these dynamics can aid in formulating more targeted interventions and policy strategies to address gynecomastia's affect on adolescent well-being.

22 July 2023 in Journal of Travel Medicine
Verified
Journal Article
Closed access
PDF file
OBOri Berger
Ori Berger
Mor Nadia Lurie-WeinbergerMor Nadia Lurie-Weinberger
Mor Nadia Lurie-Weinberger
ETEvgenia Tsyba
Evgenia Tsyba
RTRan Talisman
Ran Talisman
Medical tourism for cheaper aesthetic surgeries in countries like Turkey may result in infections like carbapenem-resistant Pseudomonas aeruginosa. Bioinformatics analysis of a reported case in Israel revealed a highly virulent and antibiotic-resistant strain, emphasizing the need for infection control and appropriate antibiotic use in medical tourism.

2 December 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
OBOri Berger
Ori Berger
SMShaked Menashe
Shaked Menashe
SGShiri Damti Geva
Shiri Damti Geva
RYReychel Yakubov
Reychel Yakubov
MYMaor Ben Yehuda
Maor Ben Yehuda
RTRan Talisman
Ran Talisman
Introduction: Lipomas are the most common benign adipocytic tumors and are traditionally regarded as incidental findings with cosmetic significance. However, their frequent occurrence in adults with obesity and metabolic risk factors raises the possibility that lipomas may reflect systemic metabolic dysfunction rather than isolated adipose overgrowth. The present study evaluated whether adults with lipomas have a higher prevalence of metabolic syndrome components, obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus (T2DM), compared with population benchmarks. Methods: We conducted a retrospective, multicenter, cross-sectional analysis of electronic health records from three Israeli hospitals (Barzilai, Shamir, and Galil Medical Centers) between January 2000 and December 2022. Adults aged ≥21 years with a clinical diagnosis of lipoma (ICD-9-CM 214) were included. Data were harmonized using the Observational Medical Outcomes Partnership (OMOP) Common Data Model and analyzed via the Lynx real-world health data platform. Prevalence of obesity, dyslipidemia, hypertension, and T2DM was compared against age- and sex-specific benchmarks from the 2023 Israeli Knowledge, Attitudes, and Practices (KAP) survey. Subgroup comparisons used Z-tests or exact binomial tests with α = 0.05, reporting absolute differences with 95% confidence intervals. Results: A total of 7,868 adults with lipomas were analyzed (mean [SD] age, 53.0 [15.0] years; 53.6% women). Compared with population benchmarks, lipoma patients showed consistently higher prevalence of all four metabolic traits. Dyslipidemia was most overrepresented, followed by hypertension and obesity, while T2DM showed a uniform excess across all age and sex subgroups. Clustering of three or more metabolic traits—consistent with metabolic syndrome, was common after age 35 and most pronounced in midlife. Conclusion: Adults with lipomas exhibit a substantially higher burden of metabolic syndrome components compared with population norms. These findings suggest that lipomas may serve as visible clinical indicators of systemic metabolic dysfunction. Recognizing lipomas as potential cutaneous markers of cardiometabolic risk could improve early identification of individuals at risk for obesity-related and endocrine diseases and support integration of dermatologic and metabolic screening practices.

1 October 2024 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
OBOri Berger
Ori Berger
MMMor Bsc Mendelson
Mor Bsc Mendelson
DGDavid Goren
David Goren
AAAndrey Andrakhanov
Andrey Andrakhanov
RTRan Talisman
Ran Talisman
Background: Giant cell tumor of bone (GCTB) is a locally aggressive tumor that may affect the bones of the hand and rarely causes pulmonary metastasis. It exhibits a variable recurrence rate after surgical interventions, which presents challenges in its management. This systematic review aims to delineate recurrence rates and identify risk factors for GCTB in the hand. Methods: We conducted a systematic literature search in April 2024, following PRISMA guidelines, on PubMed and TDNet for studies reporting postsurgical recurrence of GCTB in the hand. Cohort and case-control studies provided recurrence rates, whereas case reports and series were utilized to identify risk factors, compensating for the sparse data in the primary studies. We used descriptive statistics, χ2 tests, and logistic regression to analyze demographics, lesion characteristics, treatments, and outcomes. Results: We reviewed 13 cohort and case-control studies involving 244 patients, finding an overall recurrence rate of 19.57%. Curettage was associated with higher recurrence rates compared with other surgical methods. After additional review of case reports, a limited range of motion in patients emerged as a significant protective factor against recurrence, suggesting potential benefits in surgical management and outcome prediction. Conclusions: The significant recurrence rate associated with curettage highlights the need for alternative surgical strategies in GCTB management of the hand. The protective role of limited ROM underscores the importance of thorough preoperative assessments to optimize surgical approaches and enhance patient outcomes.

2 May 2024 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
OBOri Berger
Ori Berger
BLBernardo A. Lomeli
Bernardo A. Lomeli
AAAndrey Andrakhanov
Andrey Andrakhanov
RTRan Talisman
Ran Talisman
Summary: Wartenberg syndrome, also known as Cheiralgia paresthetica, is an uncommon neuropathy affecting the superficial branch of the radial nerve. Typically caused by external compression, it manifests as paresthesia or pain in the radial side of the hand. We present a case of Wartenberg syndrome resulting from combat shrapnel injury, illustrating an uncommon etiology. A 21-year-old soldier was presented with allodynia and paresthesia after a shrapnel explosion, with positive clinical findings and radiographic evidence supporting the diagnosis. Nonoperative management led to significant improvement, highlighting the importance of conservative treatment in such cases. This report underscores the significance of considering unconventional causes in nerve entrapment syndromes post combat trauma, emphasizing adherence to established therapeutic guidelines.

1 May 2024 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
OBOri Berger
Ori Berger
RTRan Talisman
Ran Talisman
Background:Breast reconstruction is a standard procedure in postmastectomy plastic surgery. The necessity of routine histological examinations for mastectomy scars during delayed reconstruction remains a topic of debate. We evaluated the need for histological examination of scars during delayed breast reconstruction.Methods:We conducted a systematic review using PubMed, TDnet, and Cochrane Central in August 2023. Inclusion criteria involved delayed breast reconstruction with histological scar analysis and malignancy reporting. Exclusion criteria encompassed noncancerous breast diseases, prophylactic mastectomies, articles lacking relevant information, case reports, technique descriptions, and reviews. We independently assessed articles. Differences in recurrence rates were determined using a Z-test for proportions. A linear regression model explored the relationship between reconstruction timing and pathological results. The number needed to treat was calculated based on the literature. The Wilcoxon test was used to compare mean reconstruction times and postreconstruction follow-up between groups.Results:Our analysis covered 11 retrospective observational studies published between 2003 and 2018, including 3754 mastectomy scars. The malignancy recurrence rate was 0.19%, consistent with previous reports, with a number needed to treat of 144.93-188.68 patients. The timing of breast reconstruction postmastectomy averaged 19.9 months, without statistically significant association between reconstruction timing and recurrence rates. Postreconstruction follow-up periods ranged from 60 to 87 months. The postreconstruction adverse outcomes ratio was 2.21%.Conclusions:Assessing the necessity of histological examination in breast reconstruction is complex. Based on the literature and this study, we do not recommend routine histological examination of mastectomy scars during delayed reconstruction. A selective approach based on risk factors may be beneficial, warranting further research.